Structure of Protein Pair Provides Blueprint for Future Drugs

New MPN research for medications

Publishers Note: Researcher Associate Professor Jeff Babon advises: This is very early stage research.  It gives us the blueprint to begin to develop a medicine that targets the molecule, JAK2, that is responsible for PV and other MPNs in a novel way, the same way that is used by own our natural JAK2-inhibitory protein (called SOCS1). […]

An Opportunity to improve measurement of health related quality of life symptoms using MPN Patient reported outcomes

blood test results mpn

A Patient’s Perspective – Methods to Improve MPN Research by Collecting data and Blood test results from Patients by David Wallace As a PV patient, my treatment has run a wide spectrum during the last 6 years.  Starting with phlebotomy only, Hydroxyurea (short time frame), Pegasys (nearing 2 years) and now the “cutting edge combo” […]

error: Content is protected !
Malcare WordPress Security